After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics.

@article{Lexchin1997AfterCL,
  title={After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics.},
  author={Joel Lexchin},
  journal={Health policy},
  year={1997},
  volume={40 1},
  pages={
          69-80
        }
}
Bills C-22 and C-91 eliminated compulsory licensing for pharmaceutical products in Canada. However, in the wake of these bills there are pressing issues of pharmaceutical policy that need to be decided. The value of additional spending in pharmaceutical R and D has yet to be evaluated. There needs to be a public debate about how far government policy should go in encouraging pharmaceutical R and D as opposed to investing resources in other areas. There has been a continuing escalation in the… CONTINUE READING
BETA